Novel Receptor:Ligand Interactions in Osteolytic Diseases.
Category
FP7 Project with U.S. partner
Short name and number
NRLIOD (236932)
Area
No theme specific
Description
Pathological bone loss (osteolysis), the process whereby osteoclasts erode mineralised bone matrix, remains an unresolved challenge in the pathology of osteolytic diseases, such as osteoporosis, rheumatoid arthritis (RA) and osteolytic bone cancers. Identification of the receptors involved in osteoclast development (osteoclastogenesis) is currently a high priority in osteoclast research.
Participating Countries
United Kingdom and United States.
Name of US Partner
UNIVERSITY OF WASHINGTON
Contact
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE (UK) / MURPHY Edna